Innovative Combination Therapy Demonstrates Promising Results in Aggressive Leukemia: Insights from the RELAX Study in Dresden
Acute Myeloid Leukemia (AML) represents one of the most aggressive and formidable hematologic malignancies, characterized by rapid proliferation of abnormal ...
